
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
[ Tue, Mar 26th 2024 ]: WOPRAI
Andrew Fein Maintained (STRO) at Strong Buy and Held Target at $16 on, Mar 26th, 2024


🞛 This publication is a summary or evaluation of another publication
Andrew Fein of HC Wainwright & Co., Maintained "Sutro Biopharma, Inc." (STRO) at Strong Buy and Held Target at $16 on, Mar 26th, 2024.
Andrew, nor any peers, have made any analyst calls on STRO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30